{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Primary lymphoedema",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_bendamustine",
          "name": "Bendamustine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon alpha"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_lymphedema_compression_pump",
          "name": "Lymphedema compression pump"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_pantoprazole",
          "name": "Pantoprazole"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tamoxifen",
          "name": "Tamoxifen"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_trastuzumab",
          "name": "Trastuzumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_bendamustine",
          "type": "Target",
          "label": "OffTarget_Bendamustine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bendamustine",
          "type": "Pathway",
          "label": "RiskPath_Bendamustine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bendamustine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Bendamustine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_dexamethasone",
          "type": "Target",
          "label": "OffTarget_Dexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_dexamethasone",
          "type": "Pathway",
          "label": "RiskPath_Dexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_dexamethasone",
          "type": "Phenotype",
          "label": "AdversePhenotype_Dexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_bendamustine",
          "target": "n_ot_bendamustine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在对非靶组织的影响"
        },
        {
          "source": "n_ot_bendamustine",
          "target": "n_rp_bendamustine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的不良路径"
        },
        {
          "source": "n_rp_bendamustine",
          "target": "n_adv_bendamustine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_adv_bendamustine",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则可能抵消疗效"
        },
        {
          "source": "drug_dexamethasone",
          "target": "n_ot_dexamethasone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "存在潜在干扰靶组织的风险"
        },
        {
          "source": "n_ot_dexamethasone",
          "target": "n_rp_dexamethasone",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关的不良路径风险"
        },
        {
          "source": "n_rp_dexamethasone",
          "target": "n_adv_dexamethasone",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_adv_dexamethasone",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则可能抵消疗效"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "效果与副作用的平衡",
          "pro_nodes": [
            "H1",
            "H2"
          ],
          "con_nodes": [
            "n_adv_bendamustine",
            "n_adv_dexamethasone"
          ],
          "note": "急性疗效与潜在长期风险之间存在冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "Bendamustine可能具有免疫抑制或其他有害影响",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "Dexamethasone可能导致体液潴留与合成代谢增强",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "对靶组织的影响是否得到验证",
      "可能的免疫干扰机制是否被考虑"
    ],
    "falsification_tests": [
      "查找是否有数据表明这些药物对淋巴水肿有效",
      "是否存在严重不良反应的病例报告"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供更明确的药物机制与风险评估",
      "考虑对冲突热点的进一步研究"
    ]
  }
}